Background: Clinical practice guidelines state that mobility is supposed to play an important role in determining use and duration of pharmacologic VTE prophylaxis. This study examines whether measured mobility levels relate to pharmacologic VTE prophylaxis use among hospitalized older adults. Methods: Prospective observational data from a sample of community-dwelling older adults aged ≥ 60 years, [...]

Background: Venous thromboembolism (VTE) is a major cause of morbidity and mortality in the United States. The increased risk of VTE among medically ill older adults is firmly established. Guidelines strongly promote the use of pharmacologic VTE prophylaxis in this population, yet studies have suggested sub-optimal prophylaxis rates. Our study aimed to describe current provider [...]

Background: Venous Thromboembolism (VTE) is a potentially life-threatening disorder and in some cases, is related to underlying hypercoagulability which may be congenital or acquired. Guidelines suggest performing extensive work -up for hypercoagulability only in select patients: those with close family history of VTE at young age ( < 45), young age at first VTE (<45), [...]

Background: Despite strong performance on Venous Thromboembolism (VTE) Core Measures, our institutional approach to VTE prophylaxis placed significant burden on providers through frequent automated alerts. Within our Electronic Medical Record (EMR), provider alerts triggered when a patient with at least one identified risk factor for VTE did not have prophylactic medication ordered. However, only 11% [...]

Background: Risk factors for hospital-acquired venous thromboembolism (HA-VTE) have been well-studied in adults, with validated risk assessment tools available. Adults admitted to children’s hospitals are younger but with comorbidities stemming from childhood conditions. There is a paucity of data on HA-VTE characteristics and risk factors in this population. Our objective was to evaluate HA-VTE in [...]